A 64-year-old with recurrent CDI after two fidaxomicin courses and a vancomycin taper continues to relapse. What is the next evidence-based option?...

Question

A 64-year-old with recurrent CDI after two fidaxomicin courses and a vancomycin taper continues to relapse. What is the next evidence-based option?

Accepted Answer

Fecal microbiota transplantation

Answer

Probiotics only

Answer

Repeat metronidazole

Answer

Prolonged vancomycin suppression indefinitely

Answer

Rifaximin monotherapy

us-usmle-step-2 MCQ (SBA): Refractory CDI